Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Consuelo Cháfer–Pericas"'
Publikováno v:
Pharmacological Research, Vol 212, Iss , Pp 107595- (2025)
Externí odkaz:
https://doaj.org/article/6ebc8e51c18841c0b389d891641dbc7d
Autor:
Laura Ferré-González, Ángel Balaguer, Marta Roca, Artemis Ftara, Ana Lloret, Consuelo Cháfer-Pericás
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-14 (2024)
Abstract Background Alzheimer's disease (AD) is the most prevalent dementia, showing higher incidence in women. Besides, lipids play an essential role in brain, and they could be dysregulated in neurodegeneration. Specifically, impaired plasma lipid
Externí odkaz:
https://doaj.org/article/ba05f22238204ee781da24873d35d525
Autor:
Mar García-Zamora, Gemma García-Lluch, Lucrecia Moreno Royo, Consuelo Cháfer-Pericás, Juan Pardo Albiach
Publikováno v:
Pharmacological Research, Vol 208, Iss , Pp 107396- (2024)
Externí odkaz:
https://doaj.org/article/10c9ec16898340278b55227267044168
Autor:
Laura Ferré-González, Ángel Balaguer, Marta Roca, Artemis Ftara, Ana Lloret, Consuelo Cháfer-Pericás
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Lipids are the major component of the brain with important structural and functional properties. Lipid disruption could play a relevant role in Alzheimer’s disease (AD). Some brain lipidomic studies showed significant differences compared
Externí odkaz:
https://doaj.org/article/5ffdce1e466f45598095dea9258088c2
Autor:
Laura Ferré-González, Ángel Balaguer, Marta Roca, Artemis Ftara, Ana Lloret, Consuelo Cháfer-Pericás
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/24207ff00cac41ada187e1529fd8f95c
Autor:
Carmen Peña-Bautista, Adrián Tarazona-Sánchez, Aitana Braza-Boils, Angel Balaguer, Laura Ferré-González, Antonio J. Cañada-Martínez, Miguel Baquero, Consuelo Cháfer-Pericás
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract The microRNAs (miRNAs) are potential biomarkers for complex pathologies due to their involvement in the regulation of several pathways. Alzheimer Disease (AD) requires new biomarkers in minimally invasive samples that allow an early diagnosi
Externí odkaz:
https://doaj.org/article/4ff797ebd4cb47b8a22add05d8f834d3
Autor:
Carmen Peña-Bautista, Rakesh Kumar, Miguel Baquero, Jan Johansson, Consuelo Cháfer-Pericás, Axel Abelein, Daniel Ferreira
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: Dementia with Lewy Bodies (DLB) is the second most common cause of neurodegenerative dementia after Alzheimer’s disease (AD), but the field is still lacking a specific biomarker for its core pathology: alpha synuclein (α-syn). Realti
Externí odkaz:
https://doaj.org/article/489490a372ab4021b2a8b418020cff66
Autor:
Gemma García-Lluch, Carmen Peña-Bautista, Lucrecia Moreno Royo, Miguel Baquero, Antonio José Cañada-Martínez, Consuelo Cháfer-Pericás
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 924 (2023)
(1) Background: The role of antihypertensives in Alzheimer’s Disease (AD) prevention is controversial. This case-control study aims to assess whether antihypertensive medication has a protective role by studying its association with amyloid and tau
Externí odkaz:
https://doaj.org/article/792744b116bf4dd4808e03b26d2c1af2
Autor:
Lorena García-Vallés, Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer-Cairols, Miguel Baquero, Consuelo Cháfer-Pericás
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2880 (2022)
Introduction: Early and accurate Alzheimer’s disease (AD) diagnosis has evolved in recent years by the use of specific methods for detecting its histopathological features in concrete cases. Currently, biomarkers in cerebrospinal fluid (CSF) and im
Externí odkaz:
https://doaj.org/article/a3a7da21b79e44fba9131b67d45f9b48
Publikováno v:
Antioxidants, Vol 11, Iss 3, p 551 (2022)
Alzheimer’s disease (AD) and other dementias are becoming increasingly common in the older population, and the number of people affected is expected to increase in a few years. Nowadays, biomarkers used in early AD diagnosis are expensive and invas
Externí odkaz:
https://doaj.org/article/14b92459214244a28622bd8a4f36ecb1